The patient was a 49-year-old female who presented with an EGFR mutation (exon 19) with wild-type KRAS and ALK. The patient had previously undergone surgery twice for condyloma acuminatum, and had stage I adenocarcinoma. Here, EGFR is linked to adenocarcinoma.